Insider · CIK 0002088597
Stephen Hui Wang
Files at IMA (Ikena Oncology, Inc.). First filing -, latest -.
In brief
Stephen Hui Wang files SEC Form 4 as director at IMA (Ikena Oncology, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Stephen Hui Wang has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | IMA Ikena Oncology, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +31,200 | $0.00 | $0 | 31,200 | Dec 22, 2025 |
| Jul 25, 2025 | IMA Ikena Oncology, Inc. | AGrant or award Common Stockindirect: HLC Healthcare HK Limited | +188,042 | - | - | 188,042 | Oct 10, 2025 |
| Jul 25, 2025 | IMA Ikena Oncology, Inc. | AGrant or award Common Stockindirect: By Galaxy Alpha L.P. | +50,144 | - | - | 50,144 | Oct 10, 2025 |
| Jul 25, 2025 | IMA Ikena Oncology, Inc. | AGrant or award Common Stockindirect: By Magic Hat L.P. | +12,535 | - | - | 12,535 | Oct 10, 2025 |
Questions about Stephen Hui Wang
Answered from the filings on this page, as of the latest one.
Is Stephen Hui Wang buying or selling?
Stephen Hui Wang has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Stephen Hui Wang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Stephen Hui Wang has 0.
Where does Stephen Hui Wang file Form 4?
Stephen Hui Wang has filed Form 4 at IMA (Ikena Oncology, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.